Pfizer’s Cardura XL Clears FDA For Benign Prostatic Hyperplasia
This article was originally published in The Pink Sheet Daily
Executive Summary
The extended-release formulation of doxazosin has a narrower indication than the immediate-release formulation but allows for less frequent dose titration. Both formulations are once-daily.